These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4022195)

  • 21. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man.
    Jelinek DF; Lipsky PE
    J Immunol; 1983 Jun; 130(6):2597-604. PubMed ID: 6189896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea.
    Müller A; Boitier E; Hu T; Carr GJ; Le Fèvre AC; Marchandeau JP; Flor M; Jefferson F; Aardema MJ; Thybaud V
    Environ Mol Mutagen; 2005 Dec; 46(4):221-35. PubMed ID: 16127667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effect of hydroxyurea and methotrexate on DNA fragmentation at various reaction conditions.
    Golos B; Malec J
    Neoplasma; 1991; 38(6):559-64. PubMed ID: 1766482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of hydroxyurea in spinal muscular atrophy cells and patients.
    Liang WC; Yuo CY; Chang JG; Chen YC; Chang YF; Wang HY; Ju YH; Chiou SS; Jong YJ
    J Neurol Sci; 2008 May; 268(1-2):87-94. PubMed ID: 18166199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain.
    Woo GH; Bak EJ; Nakayama H; Doi K
    Neurotoxicol Teratol; 2006; 28(1):125-34. PubMed ID: 16356682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron chelators hydroxyurea and bathophenanthroline disulfonate inhibit DNA synthesis by different pathways.
    Alcaín FJ; Löw H; Crane FL; Navas P
    Biochem Mol Biol Int; 1994 Sep; 34(2):273-9. PubMed ID: 7849637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell cycle phase specificity of hydroxyurea and its effects on the cell kinetics in embryonic spinal cord.
    Herken R
    Teratology; 1980 Feb; 21(1):9-14. PubMed ID: 7385059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of deoxycytidine monophosphate (dCMP) on the cytotoxicity of hydroxyurea in the embryonic spinal cord of the mouse.
    Herken R
    Teratology; 1984 Aug; 30(1):83-90. PubMed ID: 6484855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of L5178Y cells by vitamin E against acute hydroxyurea toxicity does not change the efficiency of ribonucleotide reductase-mediated hydroxyurea-induced cytotoxic events.
    Przybyszewski WM; Kopeć-Szlezak J; Malec J
    Cancer Lett; 1987 Mar; 34(3):337-44. PubMed ID: 3548948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resonance nature of the relation of mouse survival to the interval between administrations of the S-specific agent--hydroxyurea].
    Dibrov BF; Ataullakhanov AN; Gel'fand EV; Zhabotinskiĭ AM; Neĭfakh IuA
    Biull Eksp Biol Med; 1986 Nov; 102(11):594-6. PubMed ID: 3779090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA metabolism during infection of Anacystis nidulans by cyanophage AS-1. VI. Effect of hydroxyurea and nalidixic acid on the development of cyanophage AS-1.
    Lee HL; Cohn G; Blamire J; McGowan R
    Microbios; 1985; 43(176S):245-59. PubMed ID: 3938513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radical mechanism of hydroxyurea side toxicity].
    Przybyszewski WM; Kasperczyk J
    Postepy Hig Med Dosw (Online); 2006; 60():516-26. PubMed ID: 17060893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against hydroxyurea-induced cytotoxic effects in L5178Y cells by free radical scavengers.
    Przybyszewski WM; Malec J
    Cancer Lett; 1982; 17(2):223-8. PubMed ID: 6299514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of differences in the circadian profiles of DNA synthesis between normal and neoplastic cell populations by hydroxyurea without perturbation of the normal circadian rhythms.
    Burns ER
    Oncology; 1983; 40(6):410-20. PubMed ID: 6646608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyurea.
    Timson J
    Mutat Res; 1975; 32(2):115-32. PubMed ID: 765790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.